John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$175M |
| 2 |
Meta Platforms (Facebook)
META
|
+$163M |
| 3 |
ABMD
Abiomed Inc
ABMD
|
+$138M |
| 4 |
Constellation Brands
STZ
|
+$135M |
| 5 |
Johnson & Johnson
JNJ
|
+$132M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$173M |
| 2 |
Pfizer
PFE
|
+$159M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$136M |
| 4 |
Dominion Energy
D
|
+$133M |
| 5 |
eBay
EBAY
|
+$118M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.76% |
| 2 | Consumer Discretionary | 11% |
| 3 | Industrials | 10.42% |
| 4 | Healthcare | 9.63% |
| 5 | Financials | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FFWM
1151
DELISTED
First Foundation Inc
FFWM
| $4M | 0.01% |
215,858
+141,703
| +191% | +$2.68M |
|
1152
Vanguard Morningstar Growth ETF
VUG
$224B
| $4M | 0.01% |
160,200
+122,400
| +324% | +$3M |
|
|
RVNC
1153
DELISTED
Revance Therapeutics, Inc.
RVNC
| $4M | 0.01% |
145,677
+97,822
| +204% | +$2.94M |
|
|
COL
1154
DELISTED
Rockwell Collins
COL
| $3.97M | 0.01% |
+29,496
| New | +$3.99M |
|
|
EGIO
1155
DELISTED
Edgio, Inc. Common Stock
EGIO
| $3.96M | 0.01% |
22,177
+348
| +2% | +$67.5K |
|
1156
GeoPark
GPRK
$639M
| $3.96M | 0.01% |
192,750
+80,192
| +71% | +$1.27M |
|
1157
CALL
Albemarle
ALB
$16.7B
| $3.93M | 0.01% |
41,700
+39,300
| +1,638% | +$3.77M |
|
|
ODP
1158
DELISTED
ODP
ODP
| $3.93M | 0.01% |
+154,045
| New | +$3.74M |
|
1159
CALL
Weyerhaeuser
WY
$17.6B
| $3.92M | 0.01% |
107,400
+17,500
| +19% | +$640K |
|
1160
CVB Financial
CVBF
$3.95B
| $3.91M | 0.01% |
+174,350
| New | +$4.01M |
|
|
1161
PUT
eBay
EBAY
$47.7B
| $3.9M | 0.01% |
107,700
+59,800
| +125% | +$2.33M |
|
|
I
1162
DELISTED
INTELSAT S. A.
I
| $3.9M | 0.01% |
+234,209
| New | +$3.03M |
|
1163
PUT
Humana
HUM
$46.4B
| $3.87M | 0.01% |
13,000
-1,600
| -11% | -$469K |
|
1164
Goldman Sachs
GS
$302B
| $3.85M | 0.01% |
17,474
+11,597
| +197% | +$2.77M |
|
1165
CALL
Cognizant
CTSH
$28B
| $3.85M | 0.01% |
+48,700
| New | +$3.83M |
|
|
STML
1166
DELISTED
Stemline Therapeutics, Inc.
STML
| $3.85M | 0.01% |
+239,597
| New | +$4.28M |
|
1167
Avery Dennison
AVY
$13.9B
| $3.85M | 0.01% |
+37,660
| New | +$3.98M |
|
1168
Direxion Daily S&P 500 Bull 3x ETF
SPXL
$6.82B
| $3.83M | 0.01% |
86,000
+24,700
| +40% | +$1.08M |
|
1169
PUT
iShares MSCI Japan ETF
EWJ
$22.4B
| $3.81M | 0.01% |
+65,800
| New | +$3.96M |
|
1170
Strategic Education
STRA
$1.87B
| $3.81M | 0.01% |
33,668
+2,550
| +8% | +$273K |
|
1171
PUT
Philip Morris
PM
$298B
| $3.79M | 0.01% |
47,000
-103,500
| -69% | -$8.78M |
|
1172
PUT
Simon Property Group
SPG
$71.4B
| $3.79M | 0.01% |
22,300
-103,900
| -82% | -$16.5M |
|
1173
Madrigal Pharmaceuticals
MDGL
$11.8B
| $3.79M | 0.01% |
+13,549
| New | +$2.38M |
|
1174
Wheaton Precious Metals
WPM
$72.8B
| $3.78M | 0.01% |
171,515
+119,118
| +227% | +$2.56M |
|
|
AVB
1175
CALL
DELISTED
AvalonBay Communities
AVB
| $3.78M | 0.01% |
22,000
+13,600
| +162% | +$2.25M |
|
Similar funds
John Overdeck's Q2 2018 Portfolio in Review
As of Q2 2018, John Overdeck held 3,907 positions worth $33.5B, up 12% from $30B the previous quarter. Its ten largest holdings account for 5.6% of the portfolio.
John Overdeck deployed $2.27B of net new capital in Q2 2018, opening 829 new positions and adding to 1,295 existing holdings. Its largest new stake was Alphabet (Google) Class A: 3,215,020 shares worth $182M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was Booking.com, an estimated $173M trimmed.
- John Overdeck's largest Q2 2018 buy was Alphabet (Google) Class A: 3,215,020 shares worth $182M.
- John Overdeck added most to Abiomed Inc in Q2 2018, an estimated $138M increase.
- John Overdeck's biggest Q2 2018 reduction was Booking.com, cutting an estimated $173M.
- John Overdeck fully exited Pfizer in Q2 2018, selling an estimated $159M.
- John Overdeck's ten largest holdings make up 5.6% of its $33.5B portfolio in Q2 2018.
- John Overdeck opened 829 new positions and closed 662 in Q2 2018.
- John Overdeck's portfolio value rose 12% quarter-over-quarter to $33.5B.
Based on Two Sigma Investments's 13F filing for Q2 2018, filed 14 Aug 2018.